$0.78
+0.02 (+2.05%)
Open$0.78
Previous Close$0.77
Day High$0.81
Day Low$0.76
52W High$3.36
52W Low$0.47
Volume—
Avg Volume462.2K
Market Cap7.64M
P/E Ratio—
EPS$-0.88
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,458.0% upside
Current
$0.78
$0.78
Target
$27.92
$27.92
$15.39
$27.92 avg
$30.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 51.26M | 62.87M | 3.60M |
| Net Income | -5,452,497 | -6,018,208 | 438.1K |
| Profit Margin | -10.6% | -10.1% | 12.2% |
| EBITDA | -2,769,232 | -3,226,355 | 810.0K |
| Free Cash Flow | — | — | 302.1K |
| Rev Growth | -18.5% | -18.5% | +16.0% |
| Debt/Equity | — | — | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |